Author + information
- Received February 27, 2002
- Revision received May 12, 2002
- Accepted May 31, 2002
- Published online October 16, 2002.
- Hung-Fat Tse, MD, FACC*,* (, )
- Cannas Yu, MPhil*,
- Kwong-Kuen Wong, MBBS†,
- Vella Tsang, RN*,
- Yim-Lung Leung, MBBS†,
- Wai-Yin Ho, MBBS† and
- Chu-Pak Lau, MD, FACC*
- ↵*Reprint requests and correspondence:
Dr. Hung-Fat Tse, Cardiology Division, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Objectives We sought to evaluate the long-term effects of alternative right ventricular pacing sites on myocardial function and perfusion.
Background Previous studies have demonstrated that asynchronous ventricular activation due to right ventricular apical (RVA) pacing alters regional myocardial perfusion and functions.
Methods We randomized 24 patients with complete atrioventricular block to undergo permanent ventricular stimulation either at the RVA (n = 12) or right ventricular outflow (RVOT) (n = 12). All patients underwent dipyridamole thallium myocardial scintigraphy and radionuclide ventriculography at 6 and 18 months after pacemaker implantation.
Results After pacing, the mean QRS duration was significantly longer during RVA pacing than during RVOT pacing (151 ± 6 vs. 134 ± 4 ms, p = 0.03). At six months, the incidence of myocardial perfusion defects (50% vs. 25%) and regional wall motion abnormalities (42% vs. 25%) and the left ventricular ejection fraction (LVEF) (55 ± 3% vs. 55 ± 1%) were similar during RVA pacing and RVOT pacing (p > 0.05). However, at 18 months, the incidence of myocardial perfusion defects (83% vs. 33%) and regional wall motion abnormalities (75% vs. 33%) were higher and LVEF (47 ± 3 vs. 56 ± 1%) was lower during RVA pacing than during RVOT pacing (all p < 0.05). Patients with RVA pacing had a significant increase in the incidence of myocardial perfusion defects (p < 0.05) and a decrease in LVEF (p < 0.01) between 6 and 18 months, but patients with RVOT pacing did not (p > 0.05).
Conclusions This study demonstrates that preserved synchronous ventricular activation with RVOT pacing prevents the long-term deleterious effects of RVA pacing on myocardial perfusion and function in patients implanted with a permanent pacemaker.
- Received February 27, 2002.
- Revision received May 12, 2002.
- Accepted May 31, 2002.
- American College of Cardiology Foundation